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MouseThe morphogen Sonic hedgehog, one of the Hedgehog (Hh) family of secreted proteins, plays a key role in
patterning the mammalian spinal cord along its dorsoventral (D/V) axis through the activation of Glioma-
associated oncogene (Gli) family of transcription factors. Suppressor of Fused (Sufu), a Gli-interacting pro-
tein, modulates the D/V patterning of the spinal cord by antagonizing Hh signaling. The molecular mecha-
nisms underlying the function of Sufu in Hh pathway activation and spinal cord D/V patterning remain
controversial, particularly in light of recent ﬁndings that Sufu protects Gli2 and Gli3 proteins from proteaso-
mal degradation. In the current study, we show that Hh pathway activation and dorsal expansion of ventral
spinal cord cell types in the absence of Sufu depend on the activator activities of all three Gli family proteins.
We also show that Sufu plays a positive role in the maximal activation of Hh signaling that deﬁnes the
ventral-most cell fate in the mammalian spinal cord, likely through protecting Gli2 and Gli3 proteins from
degradation. Finally, by altering the level of Gli3 repressor on a background of reduced Gli activator activities,
we reveal an important contribution of Gli3 repressor activity to the Hh pathway activation and the D/V
patterning of the spinal cord.
© 2011 Elsevier Inc. All rights reserved.Introduction
Sonic hedgehog (Shh), one of the Hedgehog (Hh) family of secret-
ed signaling molecules, plays a key role in the generation of diverse
neural progenitor cells along the dorsoventral (D/V) axis of the verte-
brate spinal cord (Dessaud et al., 2008). Shh is initially produced by
cells of the notochord, a mesodermal rod underlying the spinal cord,
and induces cells at the ventral midline of the spinal cord to form
the ﬂoor plate. The ﬂoor plate subsequently becomes an additional
source of Shh. Shh from both the notochord and ﬂoor plate forms a
ventral-to-dorsal gradient and regulates the formation of V3 inter-
neurons, motor neurons, V2 and V1 interneurons. The speciﬁcation
and locations of these neurons and their progenitors are deﬁned by
the concentration of Shh. Speciﬁcally, V3 interneurons require higher
Shh activity and are located right next to the ﬂoor plate, whereas
motor neurons, V2 and V1 interneurons are deﬁned at progressively
lower Shh concentrations and are located in more lateral parts of
the ventral spinal cord.
Shh elicits transcriptional responses in the spinal cord cells
through a family of zinc-ﬁnger domain-containing transcription fac-
tors, the Glioma-associated oncogene family (Gli1, Gli2 and Gli3)
(Matise and Joyner, 1999). In the absence of Shh, both Gli2 and Gli3
can be proteolytically processed into transcriptional repressors (Panity, 201 Life Science Building,
.
rights reserved.et al., 2006; Wang et al., 2000). Shh inhibits the processing of Gli2
and Gli3 and turns them into transcriptional activators. The proces-
sing of Gli2 is inefﬁcient in vivo, hence it mainly exists as a transcrip-
tional activator and is required for the formation of the ﬂoor plate and
most V3 interneurons in the spinal cord (Ding et al., 1998; Matise et
al., 1998; Pan et al., 2006). In contrast, Gli3 is efﬁciently processed
into a transcriptional repressor, and loss of Gli3 does not affect pat-
terning of the ventral spinal cord, but leads to a minor dorsal expan-
sion of the cells near the D/V boundary (Persson et al., 2002; Wang et
al., 2000). Interestingly, Gli2;Gli3 double mutants exhibit more severe
ventral spinal cord patterning defects than Gli2 single mutants, sug-
gesting redundant activator functions between Gli2 and Gli3 (Bai et
al., 2004; Lei et al., 2004). Gli1 appears to be an obligate activator,
but because its expression is dependent on Shh, Gli1 only plays a sec-
ondary role in enhancing Shh pathway activity in the ventral spinal
cord after its initial activation by Gli2 and Gli3 (Bai et al., 2002; Park
et al., 2000).
In mammals, one of the important negative regulators of Hh sig-
naling and Gli activities is Suppressor of Fused (Sufu). Ablation of
Sufu in mouse embryos leads to widespread activation of the Hh path-
way (Cooper et al., 2005; Svard et al., 2006). Speciﬁcally, in the Sufu
mutant spinal cord, ventral cell types such as the ﬂoor plate, V3 inter-
neurons and motor neurons are greatly expanded dorsally at the
expense of more dorsal cell types. Sufu physically associates with all
three mammalian Gli proteins and inhibits Gli-mediated Hh pathway
activation at least partially through sequestering full-length Gli proteins
in the cytoplasm (Ding et al., 1999; Kogerman et al., 1999; Pearse et al.,
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tips of the primary cilia, and it appears that Sufu trafﬁcs to the cilia in a
Gli-dependent process (Haycraft et al., 2005; Tukachinsky et al., 2010;
Zeng et al., 2010). Whether Sufu is dissociated from Gli proteins in the
presence of Shh is not clear. One study reported sustained association
between Sufu and Gli proteins (Chen et al., 2009). However, more re-
cent studies suggest that activated Gli proteins are no longer associated
with Sufu (Humke et al., 2010; Tukachinsky et al., 2010).
Paradoxically, despite the maximal activation of Hh signaling in
Sufu mutants, the levels of Gli2 and Gli3 proteins decrease drastically
in the absence of Sufu (Chen et al., 2009; Jia et al., 2009). This
decrease in Gli2 and Gli3 protein levels appears to be the result of
proteasomal degradation of these two proteins mediated by Spop/
Cul3-containing ubiquitin ligase complex; and reducing Spop in Sufu
mutant cells restores the levels of Gli2 and Gli3 proteins (Chen et
al., 2009; Zhang et al., 2006, 2009). Two hypotheses have been pro-
posed to interpret the apparent contradiction between Hh pathway
activation and decrease in Gli2 and Gli3 protein levels in Sufumutant
embryos. One hypothesis is that the short-lived activator forms of
Gli2 and Gli3, produced in the presence of Shh or in the absence of
Sufu, directly activate the Hh pathway (Humke et al., 2010;
Tukachinsky et al., 2010). The second hypothesis posits that the
decrease in Gli2 and Gli3 proteins reduces the overall Gli repressor activ-
ity, de-repressing the expression ofGli1 that activates Hh pathway in Sufu
mutant embryos (Chen et al., 2009). These alternative explanations of the
roles of Sufu in Hh signal transduction and mammalian spinal cord
patterning have not been experimentally addressed.
In the current study, we address the roles of the three Gli family
members in Hh pathway activation and spinal cord patterning in
the absence of Sufu through a series of genetic analyses. We show
that all three Gli proteins contribute to the ectopic activation of the
Hh pathway and cell fate change in the Sufumutant spinal cord. Inter-
estingly, Gli1 and Gli2, but not Gli3, are required for the maximal ac-
tivation of Hh signaling and the formation of the ﬂoor plate and V3
interneurons in the absence of Sufu. We further show that the activa-
tor activities of Gli2 and Gli3 are essential for Hh pathway activation
in Sufu mutants because removing Sufu in the absence of Gli2 and
Gli3, as in Gli2;Gli3;Sufu triple mutants, fails to activate Hh signaling
and ventralize the spinal cord. Signiﬁcantly, by reducing overall Gli
activator activities, as in Gli1;Sufu and Gli23ki;Sufu embryos, we reveal
a positive role of Sufu in the maximal activation of Hh signaling. Final-
ly, by lowering the overall Gli activator activity, we showed a repres-
sive role of Gli3 in Hh signaling and the D/V patterning of the Sufu
mutant spinal cord. Our data suggest that Sufu plays a negative role
in Hh pathway activation and ventral spinal cord patterning both by
direct inhibition of Gli2 and Gli3 activator activities and by maintain-
ing the proper level of Gli repressors. In addition, Sufu plays a positive
role in the maximal activation of Hh signaling, likely through its role
in protecting Gli2 and Gli3 proteins from degradation.
Materials and methods
Ethics statement
All animal work conducted in this report is in accordance of
national and international guidelines and was approved by IACUC
(#29195 and #29214) at Penn State University.
Mouse strains
Sufu, Gli1lacKI, Gli2lacKI, Gli23KI, Gli3Ex-J mutant mice are kept on 129S2/
SvPasCrl (Charles River Lab) background and genotyped as previously de-
scribed (Bai and Joyner, 2001; Bai et al., 2002, 2004;Maynard et al., 2002;
Svard et al., 2006). Mouse embryos at speciﬁed stages are dissected in
phosphate buffered saline (PBS) and documented using a Zeiss Discovery
microscope and a QImaging Micropublisher digital camera.Immunohistochemistry
Embryos were ﬁxed in 4% paraformaldehyde (PFA) at 4 °C for 1 h
and processed for cryosection. The sections were incubated with pri-
mary antibodies at 4 °C overnight followed by a 2 hour incubation
with ﬂuorescently labeled secondary antibodies, and mounted with
DABCO (Sigma-Aldrich). Pictures were taken using a Nikon E600
microscope and a QImaging Micropublisher Digital Camera.
Xgal histochemistry
Embryos were ﬁxed in 4% PFA at 4 °C for 1 h, washed in PBS
three times and incubated with 5-bromo-4-chloro-3-indolyl-ß-D-
galactopyranoside (Xgal) at 37 °C overnight. Pictures were taken
using a Zeiss Discovery microscope and a QImaging Micropublisher
digital camera.
RNA in situ hybridization
Embryos were ﬁxed in 4% PFA at 4 °C overnight, washed in DEPC-
treated PBS and processed for cryosection. RNA in situ hybridization
with Digoxigenin-labeled riboprobes against Gli1 and Ptch1 was per-
formed on the transverse sections through the spinal cord according
to the protocol originally described in Hoover et al. (2008). The
photos were taken using a Nikon E600 microscope and a QImaging
Micropublisher digital camera.
Western blot
E10.5 mouse embryos were dissected in cold PBS. Whole protein
lysate was prepared from individual embryos. 20 μg of lysate from
each sample was then loaded onto 7.5% SDS-PAGE gels and western
blotting was performed as described (Wang et al., 2000). The rabbit
polyclonal antibody against the N-terminal region of Gli3 was origi-
nally reported in Wang et al. (2000). Anti β-tubulin antibody
(Sigma, T4026) was used as a loading control. The result of western
blot was quantitated using NIH ImageJ.
Results
The maximal activation of Hh pathway in Sufu mutants requires Gli1
Recent studies indicated that Gli2 and Gli3, but not Gli1, are sub-
ject to Spop/Cul3-mediated degradation in the absence of Sufu
(Chen et al., 2009; Zhang et al., 2009). Therefore, it was hypothesized
that ectopic Gli1 expression, possibly as a result of decreased Gli re-
pressor activity, underlies the widespread Hh pathway activation in
Sufumutants (Chen et al., 2009). An in vitro reporter assay suggested
that Gli1 is required for the maximal activation of Hh target gene ex-
pression in the absence of Sufu. To address the contribution of Gli1 to
Hh pathway activation in vivo, we characterized Gli1;Sufu double mu-
tants. Consistent with previous reports (Bai et al., 2002; Park et al.,
2000), there is no visible morphological difference between wild
type (Fig. 1A) and Gli1 homozygous mutants (Fig. 1B) at embryonic
day (E) 10.5. Sufu mutants exhibit severe exencephaly, spina biﬁda,
twisted body axis and underdevelopment of structures posterior to
the forelimbs (Fig. 1C). Signiﬁcantly, Gli1;Sufu double homozygous
mutant embryos exhibit similar degree of exencephaly and spina biﬁda
as Sufu homozygousmutants, but showmore advanced posterior devel-
opment and straight body axis, suggesting that loss of Gli1may partially
suppress the Hh pathway defects in Sufumutants (Fig. 1D).
To analyze Hh pathway activity in greater detail, we compared the
D/V patterning of the Gli1;Sufu double mutant spinal cord with that of
Sufu single mutants. Previous studies suggested that there are subtle
differences in the patterning mechanisms between the anterior
Fig. 1. The ﬂoor plate and V3 interneurons fail to form in Gli1;Sufu double mutant embryos. (A–D) Lateral views of E10.5 wild type (A), Gli1 mutant (B), Sufumutant (C), and Gli1;
Sufu double mutant (D) embryos. Green arrowheads in C and D point to exencephaly and red arrowheads point to spina biﬁda. (E–X) Immunoﬂuorescent images of the transverse
sections of E10.5 spinal cords at the thoracic level. Dashed lines outline the spinal cords. Brackets indicate the domains of expression. (E) Foxa2 labels the ﬂoor plate in the wild type
spinal cord. (F) Floor plate formation is not affected by loss of Gli1. (G) Foxa2 is found throughout the Sufumutant spinal cord. (H) Foxa2 is absent in Gli1;Sufu double mutant spinal
cord. (I) Nkx2.2 is found in V3 interneurons and their progenitors next to the ﬂoor plate in the wild type spinal cord. (J) V3 interneuron formation is normal in Gli1 mutants. (K)
Nkx2.2+ cells are throughout the spinal cord. (L) Nkx2.2 is absent in the Gli1;Sufu double mutant spinal cord. (M) Olig2 labels the progenitors for motor neurons, which are dorsal to
V3 interneurons. (N) The motor neuron formation is normal in Gli1mutants. (O) The motor neuron domain is shifted to the dorsal region of the Sufumutant spinal cord. (P) Olig2+
domain is expanded both dorsally and ventrally in the Gli1;Sufu double mutant spinal cord. (Q) Nkx6.1 labels progenitors for most ventral spinal cord cells including V2, V3 inter-
neurons, motor neurons and ﬂoor plate. (R) Nkx6.1 domain is normal in the Gli1mutant spinal cord. (S and T) Nkx6.1 expression is found in all but the dorsal-most cells in the Sufu
mutant (S) and Gli1;Sufu double mutant (T) spinal cord. (U) Pax6 labels progenitor cells for most spinal cord neurons except for the ventral-most V3 interneurons and the ﬂoor
plate. (V) Pax6 domain is normal in Gli1mutants. (W) Pax6 expression is restricted to a few dorsal-most cells in the Sufumutant spinal cord. (X) Pax6+ cells are restricted dorsally
in the Gli1;Sufu double mutant spinal cord.
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2003). For both accuracy and completeness, throughout this study
we examined the D/V patterning of the spinal cords at both axialFig. 2. The ﬂoor plate and V3 interneurons fail to form in Gli2;Sufu double mutant embryos. (
double mutant (D) embryos. (E–X) Immunoﬂuorescent images of the transverse sections of
indicate the domains of expression. (E) Foxa2 labels the ﬂoor plate. (F) The ﬂoor plate is abs
mutants. (H) Foxa2 is absent in the Gli2;Sufu double mutant spinal cord. (I) Nkx2.2 labels
present in the ventral midline of the Gli2 mutant spinal cord. (K) The Nkx2.2 domain is do
reduced in the Gli2;Sufu double mutant spinal cord. (M) Olig2 labels the progenitors for m
(O) The motor neuron domain is dorsally shifted in the Sufumutant spinal cord. (P) The mo
spinal cord. (Q) Nkx6.1 labels most ventral progenitor cells including those for V2, V3 inte
mutant spinal cord. (S and T) Nkx6.1 expression is expanded into the dorsal regions of th
progenitor cells except for the ventral-most V3 interneurons and the ﬂoor plate. (V) Pax6 ex
regions of the Sufu mutant (W) and Gli2;Sufu double mutant (X) spinal cord.levels. The results from the anterior spinal cords are shown in
Figs. 1–3 and 5–7, and those from the posterior spinal cords are
shown in Supplemental Figs. 1–4, 6 and 7.A–D) Lateral views of E9.5 wild type (A), Gli2mutant (B), Sufumutant (C), and Gli2;Sufu
E10.5 spinal cords at the thoracic level. Dashed lines outline the spinal cords. Brackets
ent in the Gli2mutant spinal cord. (G) Foxa2 is found throughout the spinal cord in Sufu
V3 interneurons and their progenitors. (J) A reduced number of V3 interneurons are
rsally expanded in the Sufu mutant spinal cord. (L) Nkx2.2+ cells are absent or greatly
otor neurons. (N) The motor neuron domain is ventrally expanded in Gli2 mutants.
tor neuron domain is expanded both dorsally and ventrally in Gli2;Sufu double mutant
rneurons, motor neurons and the ﬂoor plate. (R) Nkx6.1 expression is normal in Gli2
e Sufu mutant (S) and Gli2;Sufu double mutant (T) spinal cord. (U) Pax6 labels most
pression is normal in Gli2mutants. (W and X) Pax6 expression is restricted to the dorsal
145J. Liu et al. / Developmental Biology 362 (2012) 141–153At E10.5, region-speciﬁc expression of a series of homeobox and
basic helix-loop-helix transcription factor genes in the spinal cord
progenitor domain deﬁnes the progenitors for various neuronal cellFig. 3. Gli3 is not required for the activation of Hh signaling and the ventralization of the sp
(B), Sufumutant (C), and Gli3;Sufu double mutant (D) embryos. (E–X) Immunoﬂuorescent im
outline the spinal cords. Brackets indicate the domains of expression. (E) Foxa2 labels the ﬂ
dorsally expanded in the Sufu mutant spinal cord. (H) Foxa2 domain is dorsally expanded
their progenitors. (J) The Nkx2.2 domain is normal in Gli3mutants. (K and L) The Nkx2.2 dom
cord. (M) Olig2 labels the progenitors for motor neurons. (N) The motor neuron formation
regions of the Sufu mutant (O) and Gli3;Sufu double mutant (P) spinal cord. (Q) Nkx6.1 lab
neurons and the ﬂoor plate. (R) Nkx6.1 expression is normal in the Gli3 mutant spinal cord
expression is present in all but the dorsal-most cells of the Gli3;Sufu double mutant spinal c
and the ﬂoor plate. (V) Pax6 is normal in Gli3mutants. (W) Pax6 expression is restricted to a
most cells of the Gli3;Sufu double mutant spinal cord.types (Dessaud et al., 2008). In the anterior spinal cord, Foxa2 is
expressed in the ﬂoor plate cells at the ventral midline of the spinal
cord (Fig. 1E). Nkx2.2 labels progenitors for V3 interneuronsinal cord in the absence of Sufu. (A–D) Lateral views of E9.5 wild type (A), Gli3 mutant
ages of the transverse sections of E10.5 spinal cords at the thoracic level. Dashed lines
oor plate. (F) Floor plate formation is not affected by loss of Gli3. (G) Foxa2 domain is
in the Gli3;Sufu double mutant spinal cord. (I) Nkx2.2 is found in V3 interneurons and
ain is dorsally expanded in the Sufumutant (K) and Gli3;Sufu double mutant (L) spinal
is normal in Gli3 mutants. (O and P) The motor neuron domain is shifted to the dorsal
els progenitors for most ventral spinal cord cells including V2, V3 interneurons, motor
. (S) Nkx6.1 expression is expanded to the entire Sufu mutant spinal cord. (T) Nkx6.1
ord. (U) Pax6 labels most progenitor cells except for the ventral-most V3 interneurons
few dorsal-most cells in the Sufumutant spinal cord. (X) Pax6 is present in the dorsal-
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genitor cells give rise to motor neurons next to V3 interneurons
(Fig. 1M). Nkx6.1 is expressed in progenitors for most ventral spinal
cord cells including the ﬂoor plate, V3 interneurons, motor neurons
and V2 interneurons (Fig. 1Q). Pax6 is present in all spinal cord pro-
genitor cells except for the ventral-most ones that give rise to V3 in-
terneurons and the ﬂoor plate (Fig. 1U). Shh activates the expression
of Foxa2, Nkx2.2 and Nkx6.1, and represses the expression of Pax6 inFig. 4. The roles of Sufu and Gli proteins in the regulation of Gli1 and Ptch1 expression
in the developing spinal cords. (A, B) Both Gli1 and Ptch1 are expressed in a ventral-to-
dorsal gradient in the ventral spinal cord but their expression is excluded from the
ventral-most cells of the spinal cord. (C, D) The expression domains of Gli1 and Ptch1
are shifted to the dorsal region of the Sufu mutant spinal cord. (E, F) The expression
of both Gli1 and Ptch1 are dorsally restricted in the Gli3;Sufu double mutant spinal
cords. (G, H) Both Gli1 (indicated by a Gli1-lacZ reporter) and Ptch1 are expressed
throughout the spinal cords in Gli1;Sufu double mutants. (I, J) Both Gli1 and Ptch1 are
expressed in the entire spinal cord, but the expression is much stronger ventrally.
The sample shown in G is a transverse section of an E9.5 embryo at the spinal cord
level with Xgal staining. Other samples shown are transverse sections of E9.5 embryos
at the spinal cord level processed for RNA in situ hybridization. White dashed lines out-
line the spinal cords and the brackets indicate the domains of gene expression in the
spinal cords.
Fig. 5. Hh pathway is not activated in Gli2;Gli3;Sufu triple mutants. (A–C) Lateral views
of E10.5 wild type (A), Gli2;Gli3 double mutant (B) and Gli2;Gli3;Sufu triple mutant (C)
embryos. Insets in B and C show the front views of the brains. Arrowheads point to the
elevated ﬂoor of the midbrain. (D–R) Immunoﬂuorescent images of the transverse sec-
tions of E10.5 spinal cords at the thoracic level. Dashed lines outline the spinal cords.
Brackets indicate the domains of expression. (D) Foxa2 labels the ﬂoor plate. (E) The
ﬂoor plate is absent in Gli2;Gli3 double mutants. (F) Foxa2 is absent in Gli2;Gli3;Sufu tri-
ple mutants. (G) Nkx2.2 labels V3 interneurons and their progenitors. (H) Nkx2.2 ex-
pression is absent in the Gli2;Gli3 double mutant spinal cord. (I) Nkx2.2 expression is
absent in the Gli2;Gli3;Sufu triple mutant spinal cord at the thoracic level. (J) Olig2 la-
bels the progenitors for motor neurons. (K and L) The motor neuron domain is expand-
ed ventrally in the Gli2;Gli3 double mutant (K) and Gli2;Gli3;Sufu triple mutant (L)
spinal cord. (M) Nkx6.1 labels progenitors for V2, V3 interneurons, motor neurons
and the ﬂoor plate. (N and O) Nkx6.1 expression is normal in the Gli2;Gli3 double mu-
tant (N) and Gli2;Gli3;Sufu triple mutant (O) spinal cord. (P) Pax6 labels most progen-
itor cells except for the ventral-most V3 interneurons and the ﬂoor plate. (Q and R)
Pax6 expression is expanded ventrally in the Gli2;Gli3 double mutant (Q) and Gli2;
Gli3;Sufu triple mutant (R) spinal cord.
Fig. 6. Sufu plays a positive role in Hh signaling during mouse spinal cord dorsoventral patterning. (A–D) Lateral views of E10.5 wild type (A), Gli23ki homozygous mutant (B), Sufu
mutant (C) and Gli23ki;Sufu double mutant (D) embryos. Inset in D shows the front view of the brain. (E–V) Immunoﬂuorescent images of the transverse sections of E10.5 spinal
cords at the thoracic level. Dashed lines outline the spinal cords. Brackets indicate the domains of expression. (E) Foxa2 labels the ﬂoor plate. (F) A few Foxa2+ cells are present in
the Gli23ki mutant spinal cord. (G) Foxa2 is absent in the Gli23ki;Sufu double mutant spinal cord. (H) Shh protein is found on the surface of the cells in the ﬂoor plate. (I) A few Shh+
cells are present in the Gli23ki mutant spinal cord. (J) Shh is absent in the Gli23ki;Sufu double mutant spinal cord. (K) Nkx2.2 is found in V3 interneurons and their progenitors. (L) A
few V3 interneurons are present in Gli23ki mutants. (M) Nkx2.2+ cells are absent in the Gli23ki;Sufu double mutant spinal cord. (N) Isl1 labels differentiated motor neurons. (O) In
the anterior Gli23ki mutant spinal cord, Isl1 domain is expanded ventrally but is still excluded from the ventral midline. (P) In Gli23ki;Sufu double mutant spinal cord, Isl1 expression
is no longer excluded from ventral midline. Its expression is also expanded dorsally. (Q) Nkx6.1 labels most ventral cells including V2, V3 interneurons, motor neurons and the ﬂoor
plate. (R and S) Nkx6.1 expression is normal in Gli23ki mutant (R) and Gli23ki;Sufu double mutant (S) spinal cords. (T) Pax6 labels most progenitor cells except for the ventral-most
V3 interneurons and ﬂoor plate. (U) Pax6 domain is normal in Gli23ki mutant spinal cord. (V) The domain of strong Pax6 expression in Gli23ki;Sufu double mutant spinal cord is
slightly more dorsally restricted than wild type, but a few cells in the ventral region show weak Pax6 expression.
147J. Liu et al. / Developmental Biology 362 (2012) 141–153the ventral spinal cord (Dessaud et al., 2008). Olig2 expression
appears to be dependent on low levels of Shh but is inhibited by the
highest level of Hh pathway activation.
Consistent with our morphological analysis and previous reports,
all the spinal cord progenitor cell types we examined are generated
in their normal locations in Gli1 homozygous mutants (Fig. 1F, J, N,
R and V) (Bai et al., 2002; Park et al., 2000). In contrast, the Sufu
mutant spinal cord is severely ventralized, with ﬂoor plate (Foxa2+;
Nkx6.1+) and V3 interneurons (Nkx2.2+; Nkx6.1+) expanded into
the dorsal region of the spinal cord (Fig. 1G, K and S). The domain
of motor neurons (Olig2+) is shifted to the dorsal–lateral region of
the spinal cord (Fig. 1O), supporting the idea of a dorsally expanded
Hh pathway activity gradient. It also indicates that some D/V posi-
tional information still exists in the Sufu mutant spinal cord. Consis-
tently, Pax6 expression is also restricted to the dorsal-most part of
the spinal cord in Sufu mutants (Fig. 1W).
In all Gli1;Sufu double mutant embryos examined, the dorsal
boundaries of the expression domains of Olig2 (n=46 sections from6 embryos) and Nkx6.1 (n=14 sections from 2 embryos) are shifted
dorsally compared to those in wild type and Gli1 mutant littermates
(Fig. 1P and T), suggesting a widespread Hh pathway activation.
Pax6 expression is also more dorsally restricted in Gli1;Sufu double
mutants than in wild type spinal cords (Fig. 1X; n=11 sections
from 2 embryos). As Gli1 activity is eliminated in these embryos,
these results suggest that ectopic activation of Gli1 is not solely re-
sponsible for the ectopic activation of Hh signaling and ventralization
of the spinal cord in Sufu mutants.
Interestingly, despite the widespread Hh pathway activation and
dorsal expansion of ventral cell types such as motor neurons and pos-
sibly V2 interneurons, cell types that require the maximal activation
of the Hh pathway, such as the ﬂoor plate and V3 interneurons, are
greatly reduced or fail to form in the Gli1;Sufu double mutant spinal
cord (Fig. 1H and L and data not shown; a total of 3 embryos were ex-
amined, among which 5 sections showed greatly reduced ﬂoor plate
whereas 19 sections showed no ﬂoor plate. As to V3 interneurons,
we found no V3 interneurons in 10 sections and greatly reduced
148 J. Liu et al. / Developmental Biology 362 (2012) 141–153number of V3 interneurons in 15 sections). Consistent with the idea
that Hh signaling is not maximally activated, the expression of Olig2
is no longer excluded from the ventral-most region of the spinal
cord in Gli1;Sufu double mutants (Fig. 1P; n=46 sections from 6 em-
bryos). From these observations we conclude that Gli1 is required for
the maximal activation of the Hh pathway, but not for the low-to-
intermediate levels of Hh signaling in Sufu mutants.
D/V patterning of the posterior (lumbar level) spinal cords in Gli1,
Sufumutants and Gli1;Sufu double mutants is similar to that of the an-
terior spinal cord, except that the loss of ﬂoor plate and V3 interneu-
rons was found in all sections examined (Supplemental Fig. 1; n=28
sections for ﬂoor plate and n=26 sections for V3 interneurons from 3
embryos). In addition, the posterior part of neural tube fails to close
in Sufumutants and Gli1;Sufu double mutants (Fig. 1C, D and Supple-
mental Fig. 1).
Maximal Hh pathway activation in Sufu mutants requires the activator
function of Gli2
The dorsal expansion of the Olig2 and Nkx6.1 expression domains
in the Gli1;Sufu double mutant spinal cord suggests that the other two
Gli family members may contribute to the ectopic activation of the Hh
pathway in Sufu mutants. To address the roles of Gli2 and Gli3 in Hh
pathway activation and spinal cord ventralization in Sufumutants, we
generated Gli2;Sufu and Gli3;Sufu double mutants, as well as Gli2;Gli3;
Sufu triple mutants. We ﬁrst characterized Gli2;Sufu double mutants.
Morphologically, Gli2 homozygous mutants exhibit variable mild de-
fects ranging from a slightly tighter mesencephalic ﬂexure to mid-
brain exencephaly at E9.5 (Fig. 2A, B and data not shown). The Gli2;
Sufu double homozygous mutant embryos are of normal size and ex-
hibit less severe defects in craniofacial and posterior development
than Sufu single mutants, suggesting that loss of Gli2 partially sup-
presses the Sufu mutant phenotype (Fig. 2C and D). However, Gli2;
Sufu double mutants exhibit more frequent and more severe exence-
phaly than Gli2 single mutants, suggesting that Gli2 activation does
not account for all ectopic Hh pathway activation in Sufu mutants.
To better understand the roles of Gli2 in Hh pathway activation
and spinal cord patterning in the absence of Sufu, we examined the
D/V patterning of the spinal cords in Gli2;Sufu double mutants. In
the Gli2 homozygous mutant spinal cords, the ﬂoor plate and most
V3 interneurons are missing and the domain of motor neurons is ex-
panded ventrally (Fig. 2F, J and N). More dorsal regions of the spinal
cords are not affected by the loss of Gli2 (Fig. 2R and V). Interestingly,
the ﬂoor plate and V3 interneurons, two cell types requiring the high-
est levels of Hh signaling, fail to form or greatly reduced in Gli2;Sufu
double mutants, suggesting that Gli2 activator activity is critical for
maximal activation of the Hh pathway in the absence of Sufu
(Fig. 2H and L; among 4 embryos examined, ﬂoor plate is absent in
24 sections, and present in reduced numbers in 6 sections; V3 inter-
neurons are absent in 16 sections and greatly reduced in 15 sections).
Consistently, motor neurons are present in the ventral-most region of
the spinal cord, indicating a lack of repression from high levels of Hh
activities (Fig. 2P; n=30 sections from 4 embryos). On the other
hand, lower levels of Hh signaling activities are present and ectopical-
ly activated in Gli2;Sufu double mutant spinal cord, because motorFig. 7. The effect of Gli3 repressor on D/V patterning of the spinal cord in the absence of S
thoracic level. Dashed lines outline the spinal cords. Brackets indicate the domains of expre
spinal cord, and weakly in some more ventrally located cells. (B) In Gli2+/−;Sufu−/−mutan
more ventral cells are expressing Pax6 at low levels. (C) In Gli23ki/+;Sufu−/− mutants, stron
ventral cells are expressing Pax6 at low levels. (D) Nkx6.1 expression is throughout the Gl
dorsal-most part of the Gli2+/−;Sufu−/− mutant spinal cord. (F) Nkx6.1 expression is exclu
is expressed in the dorsal half of the Gli2+/−;Gli3−/−;Sufu−/− mutant spinal cord. (H) Olig
Sufu−/− mutant spinal cord. (I) Olig2 expression is excluded from the dorsal-most and ven
all but the dorsal-most region of the Gli2+/−;Gli3−/−;Sufu−/− mutant spinal cord. (K) Nk
cord. (L) In Gli23ki/+;Sufu−/−mutants, strong Nkx2.2 expression is found in the ventral midl
half of the spinal cord. (M) In Gli2+/−;Gli3−/−;Sufu−/− mutants, Foxa2 expression is found
stricted to the ventral half of the spinal cord. (O) In the Gli23ki/+;Sufu−/− mutant spinal corneurons (Olig2+ and Nkx6.1+) are still expanded dorsally (Fig. 2P
and T; for Olig2+ cells, n=30 sections from 4 embryos; for
Nkx6.1+ cells, n=19 sections from 3 embryos), and the expression
domain of Pax6 is more dorsally restricted compared to wild type
(Fig. 2X; n=16 sections from 2 embryos). These data suggest that
the activator function of Gli2 is also responsible for the activation of
high levels of Hh signaling in Sufu mutants, but is not required for
the ectopic activation of lower levels of Hh signaling.
The same requirement for Gli2 in the maximal activation, but not
lower level activation, of Hh signaling is also revealed in the posterior
regions of the spinal cord (Supplemental Fig. 2).
Removing Gli3 does not change spinal cord patterning in Sufu mutants
Some previous studies suggested that in addition to strong repres-
sor activity, Gli3 also exhibits activator activity in certain contexts
(Bai et al., 2004; Lei et al., 2004; Motoyama et al., 2003). We therefore
addressed the possibility that Gli3 activator activity contributes to the
Hh pathway activation in Sufumutants. We ﬁrst investigated whether
Gli3 is required for Hh pathway activation in the absence of Sufu by
characterizing Gli3;Sufu double mutants. At E9.5, Gli3mutants exhibit
frequent exencephaly in the midbrain and anterior hindbrain, but are
otherwise similar to their wild type littermates morphologically
(Fig. 3A and B). Gli3;Sufu double mutant embryos exhibit severe
exencephaly, spina biﬁda, a twisted body and underdevelopment of
the posterior part of the body, similar to Sufu single mutants
(Fig. 3C and D). The failure to suppress the Sufu mutant phenotype
by removing Gli3 suggests that Hh pathway activation does not re-
quire Gli3 in the absence of Sufu.
To investigate whether a subtle difference exists between Sufu
mutants and Gli3;Sufu double mutants, we compared spinal cord D/
V patterning in these two mutants. The formation of the ﬂoor plate,
V2, V3 interneurons and motor neurons is not affected by loss of
Gli3 alone (Fig. 3F, J, N, R and V). In the Gli3;Sufu double mutant spinal
cord, the ﬂoor plate and V3 interneurons are dorsally expanded to the
same degree as in Sufu mutants (Fig. 3G, H, K and L; n=14 sections
from 2 Gli3;Sufu embryos for both Foxa2 and Nkx2.2). Motor neurons
are also shifted to a dorsal domain in both Gli3;Sufu double mutants
and Sufu mutants (Fig. 3O and P; n=14 sections from 2 Gli3;Sufu
double mutant embryos for Olig2). The dorsal expansion of the
Nkx6.1 domain and restriction of the Pax6 domain are also similar
in Gli3;Sufu double mutants and Sufu single mutants (Fig. 3S, T, W
and X; n=14 sections from 2 Gli3;Sufu mutant embryos for Pax6
and Nkx6.1). The same observation was made in the posterior spinal
cord (Supplemental Fig. 3). The lack of impact on the morphology and
spinal cord patterning by removing Gli3 in the Sufu mutant embryos
suggests that the Hh pathway activation in Sufu mutants does not
require Gli3 when the other two Gli proteins are present.
The expression of Gli1 and Ptch1 responds to the loss of various Gli genes
in the absence of Sufu
The expression of Gli1 and Ptch1 has been widely used as indica-
tors of Hh pathway activation in both in vivo and in vitro studies.
We thus examined the expression of these two genes in the wildufu. Immunoﬂuorescent images of the transverse sections of E10.5 spinal cords at the
ssion. (A) In Gli2+/−;Gli3−/−;Sufu−/− mutants, Pax6 is strongly expressed in the dorsal
ts, strong Pax6 expression is still restricted to the dorsal spinal cord, but it appears that
g Pax6 expression is still restricted to the dorsal spinal cord, but it appears that more
i2+/−;Gli3−/−;Sufu−/− mutant spinal cord. (E) Nkx6.1 expression is excluded from the
ded from the dorsal-most part of the Gli23ki/+;Sufu−/− mutant spinal cord. (G) Olig2
2 expression is excluded from the dorsal-most and ventral-most cells of the Gli2+/−;
tral-most cells of the Gli23ki/+;Sufu−/− mutant spinal cord. (J) Nkx2.2 is expressed in
x2.2 expression is restricted to the ventral half of the Gli2+/−;Sufu−/− mutant spinal
ine of the spinal cord. A few cells weakly expressing Nkx2.2 are scattered in the ventral
throughout the spinal cord. (N) In the Gli2+/−;Sufu−/− mutant spinal cord, Foxa2 is re-
d, Foxa2 is only expressed in the ﬂoor plate.
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cord, both Gli1 and Ptch1 are expressed in a ventral to dorsal gradient
(Fig. 4A and B). Notably, the expression of both genes is excluded
from the ventral-most region of the spinal cord, which is consistent
with a recent study suggesting that the expression of Gli1 and Ptch1is downregulated in the ﬂoor plate in response to high concentration
of Shh (Ribes et al., 2010). In Sufumutants, the expression domains of
Gli1 and Ptch1 are restricted to the dorsal parts of the spinal cord, con-
sistent with the dorsal expansion of the ﬂoor plate (Fig. 4C and D;
n=15 sections from 2 embryos for Gli1; n=9 sections from 2
150 J. Liu et al. / Developmental Biology 362 (2012) 141–153embryos for Ptch1). Interestingly, this dorsal shift of the Gli1 and
Ptch1 expression domains was also observed in Ptch1 mutant spinal
cord, which exhibits widespread Hh pathway activation (Motoyama
et al., 2003). The removal of Gli3 does not have an obvious effect on
Gli1 and Ptch1 expression as the Gli3;Sufu double mutant spinal cord
has similar dorsally restricted Gli1 and Ptch1 expression to that in
Sufu single mutants (Fig. 4E and F; n=9 sections from 2 embryos
for Gli1 and n=7 sections from 2 embryos for Ptch1).
Because the Gli1 transcript is absent in Gli1;Sufu double homozy-
gous mutants, we took advantage of the lacZ reporter gene that was
inserted into the ﬁrst coding exon of Gli1 and exhibits the same ex-
pression pattern as that of Gli1 (Bai et al., 2002). We found that
Gli1-lacZ is expressed throughout the D/V axis of the Gli1;Sufu double
mutant spinal cord (Fig. 4G; n=11 sections from 2 embryos). Simi-
larly, Ptch1 expression is also found in the entire spinal cord
(Fig. 4H; n=15 sections from 3 embryos). The ectopic expression of
Gli1 and Ptch1 in the dorsal spinal cord is consistent with the dorsal
expansion of the Olig2 and Nkx6.1 expression domains and conﬁrms
the ectopic Hh pathway activation in Gli1;Sufu double mutant spinal
cord. The expression of Gli1 and Ptch1 in the ventral-most region of
the spinal cord is consistent with the loss of ﬂoor plate and sug-
gests the lack of maximal Hh pathway activation in Gli1;Sufu double
mutants.
Similar to that in Gli1;Sufu double mutants, the expression of both
Gli1 and Ptch1 is present in the ventral part of the Gli2;Sufu double
mutant spinal cord, suggesting that the Hh pathway activation may
not be high enough to inhibit Gli1 and Ptch1 expression and deﬁne
the ﬂoor plate (Fig. 4I and J; n=8 sections from 2 embryos for Gli1;
n=17 sections from 2 embryos for Ptch1). However, the expression
of both genes in the dorsal-most regions of the spinal cord is downre-
gulated in Gli2;Sufu double mutants, which appears to suggest that
the absence of Gli2 has a more signiﬁcant impact on Hh pathway
activation than that of Gli1 in Sufu mutant spinal cord.
Gli2 and Gli3 activator activities underlie ectopic Hh pathway activation
in Sufu mutants
Our double mutant analyses thus far did not identify a single Gli
family member that is required for the ectopic activation of lower
levels of Hh signaling and dorsal expansion of the motor neurons, al-
though Gli1 and Gli2 are essential for the maximal activation of Hh
signaling. This could be interpreted as functional redundancy in the
activator activities of the three Gli family members. To address this
possibility, we characterized Gli2;Gli3;Sufu triple mutants. Both Gli2;
Gli3 double mutants and Gli2;Gli3;Sufu triple mutants exhibit mid-
brain to anterior hindbrain exencephaly at E10.5 (Fig. 5B and C). In-
terestingly, in both mutants the ﬂoors of the midbrain are elevated
(see insets in Fig. 5B and C). In the anterior part of the Gli2;Gli3 double
homozygous mutant spinal cords, the ﬂoor plate and V3 interneurons
do not form, likely due to lack of Gli activator activities (Fig. 5E and
H). Motor neuron progenitors (Olig2+ and Pax6+) consequently
expand to the ventral midline (Fig. 5K and Q). The patterning of the
more dorsal regions of the spinal cord appears to be normal, as the
dorsal boundaries of Olig2 and Nkx6.1 expression domains are not al-
tered in Gli2;Gli3 double mutants (Fig. 5K and N). In characterizing
the spinal cord D/V patterning in Gli2;Gli3;Sufu triple homozygous
mutants, the most striking ﬁnding is the lack of ectopic Hh signaling.
The ﬂoor plate is absent (Fig. 5F; n=15 sections from 3 embryos).
The V3 interneurons are absent (Fig. 5I; n=8 sections from one
embryo) or greatly reduced (data not shown; n=7 sections from
one embryo). The motor neurons are restricted to the ventral-most
region of the spinal cords (Fig. 5L; n=19 sections from 2 embryos).
Nkx6.1 is also restricted to its normal domain (Fig. 5O; n=12 sections
from 2 embryos). Pax6 expression is found throughout the spinal
cord, similar to that in Gli2;Gli3 double mutants (Fig. 5R; n=12
sections from 2 embryos).Similar expression patterns for these genes were seen in the pos-
terior spinal cords, except that no V3 interneuron was present in any
Gli2;Gli3;Sufu triple mutant sections (n=12 sections from 2 embryos)
(Supplemental Fig. 4).
In summary, our triple mutant analysis suggests that the ectopic
activation of Hh signaling and ventralization of the spinal cord in
Sufu mutants require redundant activator activities of Gli2 and
Gli3.Evidence for a positive role of Sufu in Hh pathway activation
One interesting observation we have made is the loss of the ﬂoor
plate and V3 interneurons in the Gli1;Sufu double mutant, but not in
the Gli1 single mutant spinal cord (Fig. 1 and Supplemental Fig. 1).
Because these ventral-most spinal cord cell types require the highest
exposure to Shh, this observation suggests that maximal activation of
the Hh pathway in the absence of Gli1 requires a positive function of
Sufu (Dessaud et al., 2008). This positive function of Sufu has been
predicted based on the observation that Sufu protects Gli2 and Gli3
from Spop-mediated degradation (Chen et al., 2009). Therefore, it is
possible that the activator activities of Gli2 and Gli3 are sufﬁcient to
support maximal activation of the Hh pathway without Gli1. Howev-
er, when Sufu is absent, the diminishing levels of Gli2 and Gli3 pro-
teins may not be enough for the development of cell types requiring
the maximal activation of the Hh pathway. Indeed, our Western blot
analysis indicates that the levels of full-length (Gli3-190) and total
(the full-length protein plus processed N-terminal product) Gli3 pro-
teins are drastically lower in Sufumutant and Gli1;Sufu double mutant
embryos than those in wild type and Gli1 mutant embryos (Supple-
mental Fig. 5).
To further address the positive role of Sufu, we took advantage of a
Gli23ki knock-in strain, in which the Gli2 coding region is replaced
with that of Gli3. A previous study showed that when being expressed
from the Gli2 locus, Gli3 can partially rescue the Gli2 mutant pheno-
type, suggesting that Gli3 possesses an activator activity weaker
than that of Gli2 (Bai et al., 2004). As reported, the Gli23ki homozy-
gous mutant embryos look indistinguishable from their wild type lit-
termates (Fig. 6A and B). However, the Gli23ki;Sufu double mutant
embryos are drastically different from Sufu mutants: the double mu-
tants are of normal size, with well-developed trunk and tail region,
as well as exencephaly similar to Gli2;Gli3 double mutants (Fig. 6C
and D). This suggests that Hh pathway activities are signiﬁcantly
dampened in these embryos. In the spinal cord, many V3 interneu-
rons and a small number of ﬂoor plate cells are present in Gli23ki/3ki
homozygous mutants (Fig. 6F, I and L) (Bai et al., 2004). In addition,
unlike Gli2 null mutants, Isl1-expressing motor neurons are excluded
from the ventral midline in the anterior Gli23ki mutant spinal cord,
suggesting that the activator activities of Gli3 can partially compen-
sate for Gli2 in mediating Hh signaling (Fig. 6O). However, the num-
ber of ﬂoor plate cells is greatly reduced, and V3 interneurons are
abnormally located to the ventral midline in Gli23ki mutants, suggest-
ing that the activator activity of Gli3 is not as strong as that of Gli2.
The more dorsal regions of the spinal cords are not signiﬁcantly al-
tered (Fig. 6R and U).
Interestingly, both the ﬂoor plate (n=10 sections from 2 embry-
os) and V3 interneurons (n=6 sections from 2 embryos) are absent
in Gli23ki;Sufu double mutants, concomitant with an expansion of
motor neurons to the ventral midline of the spinal cord (n=10 sec-
tions from 2 embryos) (Fig. 6G, J, M and P). The more dorsal parts
of the spinal cords are normally patterned in Gli23ki;Sufu double
mutants (Fig. 6S and V; n=16 for Nkx6.1 and n=10 for Pax6 from
2 embryos). The loss of ﬂoor plate and V3 interneurons was
also seen in the posterior spinal cords of Gli23ki;Sufu double mutants
(Supplemental Fig. 6). The complete loss of the ﬂoor plate and V3
interneurons in Gli23ki;Sufu double mutants but not in Gli23ki single
151J. Liu et al. / Developmental Biology 362 (2012) 141–153mutants provides additional support for the hypothesis that Sufu
plays a positive role in Hh signaling.
Replacing Gli2 with Gli3 dampens ectopic Hh signaling in the absence
of Sufu
In the Gli23ki;Sufu double mutant spinal cords, the motor neurons
are not only expanded ventrally, but also expanded dorsally (Fig. 6P),
indicating that the weak activator function of Gli3 can mediate low
levels of Hh pathway activation in the absence of Sufu. However, a
careful comparison with the Gli2;Sufu double mutant spinal cords re-
veals less Hh pathway activation in the Gli23ki;Sufu double mutant
spinal cords. First, the dorsal expansion of the motor neuron domain
is less dramatic in Gli23ki;Sufu double mutants (Fig. 6P; n=10 sec-
tions from 2 embryos, compared to Fig. 2P). Second, the dorsal
boundary of Nkx6.1 expression is almost completely restored in the
anterior Gli23ki;Sufu mutant spinal cord (Fig. 6S; n=16 sections
from 2 embryos). The expression of Pax6 is also restored, albeit a little
more dorsally restricted than normal, especially in the posterior re-
gion (Fig. 6V; n=10 sections from 2 embryos, Supplemental Fig. 6).
The most parsimonious explanation for this more efﬁcient rescue of
the ectopic Hh pathway activation defects in the Gli23ki;Sufu double
mutant spinal cord than that of Gli2;Sufu double mutants is that an
increase in Gli3 repressor dosage dampens Hh pathway activity,
emphasizing a role of Gli repressors in modulating Hh signaling and
spinal cord D/V patterning in the context of Sufu mutants.
The roles of Gli3 repressor activity revealed on a sensitized Gli2+/−;
Sufu−/− background
Our analyses of the double and triple homozygous mutants be-
tween Sufu and various Gli genes clearly indicate essential roles of
the activator activities of Gli proteins in mediating both the maximal
activation of Hh signaling in the ventral spinal cord and the ectopic
activation of the Hh pathway in the dorsal spinal cord. However, we
have not seen a major difference between Gli3;Sufu and Sufumutants,
which appears to argue against an essential role of (the reduction in)
Gli repressors in Hh pathway activation in Sufu mutants. Alternative-
ly, the Gli activator activities in Sufu mutants may be too strong for
the roles of Gli repressor to be revealed. To sensitize the genetic back-
ground for the investigation of Gli repressor activities, we removed
one copy of Gli2 in Sufu mutants. In the anterior spinal cord of these
Gli2+/−;Sufu−/− mutants, Pax6 is expressed in the dorsal-most re-
gion, and the expression of Nkx6.1 and Olig2 is found in all but the
dorsal-most region (Fig. 7B, E and H; n=8 sections from 2 embryos
for each gene). The domains of Nkx2.2 and Foxa2 expression are ex-
panded dorsally to occupy almost the ventral half of the spinal cord
(Fig. 7K and N; n=8 sections from 2 embryos for each gene). When
we removed Gli3 from these mutants to make Gli2+/−;Gli3−/−;
Sufu−/− triple mutants, although Pax6 expression does not appear
to change, cells expressing Nkx6.1 and Olig2 are both found in the
dorsal-most region of the spinal cord (Fig. 7A, D and G; n=8 sections
from 2 embryos for each gene). The expression domains of Nkx2.2 and
Foxa2 are also expanded more dorsally than those in Gli2+/−;Sufu−/−
mutants (Fig. 7J and M; n=8 sections from 2 embryos for each gene).
More strikingly, Olig2 expression is repressed in the ventral spinal
cord, suggesting a stronger activation of the Hh pathway when Gli3
repressor is removed (Fig. 7G; n=8 sections from 2 embryos). On
the other hand, when we introduce an extra copy of Gli3 into the
Gli2 locus to make Gli23ki/+;Sufu−/−, we found that although the do-
mains of Pax6 and Nkx6.1 expression are not altered, the dorsal ex-
pansion of Olig2 and Nkx2.2 is less severe than that in Gli2+/−;
Sufu−/− mutant spinal cord (Fig. 7C, F, I and L; n=8 sections from 2
embryos for each gene). Strikingly, ectopic Foxa2 expression is
completely abolished in the anterior spinal cord of Gli23ki/+;Sufu−/−mutants (Fig. 7O; n=8 sections from 2 embryos). We observed simi-
lar, although less obvious, effects of manipulating the levels of Gli3 re-
pressor in the posterior spinal cords of these mutants (Supplemental
Fig. 7). Therefore, our characterization of these embryos with reduced
Gli activator activities revealed an important contribution of the Gli
repressor activities to the modulation of Hh pathway activation in
the absence of Sufu.
Discussion
In the current study, we address the important question of how
Sufu regulates Hh pathway activation in the mammalian spinal cord
through its interaction with the activator and repressor forms of var-
ious Gli proteins. We ﬁrst show that the activator activities of Gli1 and
Gli2, but not Gli3, are required for the maximal activation of the Hh
pathway in the ventral spinal cord of Sufu mutants. We then show
that the ectopic activation of Hh signaling and ventralization of the
dorsal spinal cord in Sufu mutants rely on the redundant activator
function of Gli2 and Gli3. By reducing the overall activator activities
of Gli proteins, we show that Sufu serves a positive function in max-
imizing Hh pathway activation in spinal cord development. Finally,
we show that Gli repressors have an important role in modulating
Hh pathway activation and spinal cord patterning in Sufu mutants
by altering the Gli3 repressor level on a sensitized background. We
conclude that the activation of Gli activators and the reduction of
Gli repressor activities together lead to the activation of the Hh path-
way in Sufumutant embryos. Thus our studies reveal the speciﬁc and
redundant functions of the Gli proteins and the action of Sufu in mod-
ulating these activities during early neural patterning.
Sufu inhibits Hh signaling by inhibition of the activator activities of all
three Gli proteins
In vivo genetic studies revealed that the Hh pathway is broadly acti-
vated in Sufu mutant embryos (Cooper et al., 2005; Svard et al., 2006).
However, the levels of Gli2 and Gli3 proteins, including the full-length
and processed forms, are greatly reduced in the absence of Sufu (Chen
et al., 2009; Jia et al., 2009). How do we reconcile this Hh pathway acti-
vation and the reduction of Gli proteins? One possibility is that in the
absence of Sufu, Gli2 and Gli3 are turned into labile activators that
may be sufﬁcient to fully activate Hh signaling by themselves (Humke
et al., 2010). Alternatively, as recently suggested, the reduction of Gli re-
pressors, especially Gli3 repressor, may lead to deregulation of Gli1,
which in turn activates Hh signaling (Chen et al., 2009).
Our genetic analyses suggest that the activator activities of all
three Gli proteins contribute to Hh pathway activation in Sufu mu-
tants. We determined that both Gli1 and Gli2 play essential roles in
maximal activation of the Hh pathway in Sufu mutants. This is very
interesting because it demonstrates that Sufu regulates high levels
of Hh signaling both by directly inhibiting the activation of Gli2
(and likely Gli3), and by indirectly repressing the expression of Gli1.
Gli3 is not essential for Hh pathway activation in Sufumutants. How-
ever, a positive role for Gli3 in mediating Hh pathway activation in
the absence of Sufu was revealed by the following observations.
First, removing Gli2 in Sufumutants does not abolish ectopic Hh path-
way activation in the dorsal spinal cord. Although formally both Gli1
and Gli3 could underlie the ectopic Hh pathway activation in Gli2;
Sufu double mutants, the complete loss of ectopic Hh pathway activa-
tion in Gli2;Gli3;Sufu triple mutants suggests that Gli3 is essential for
the ectopic Hh pathway activation in Gli2;Sufu double mutants. In
summary, these results indicate that the activator activities of the
three Gli proteins are important for Hh pathway activation and spinal
cord ventralization in Sufu mutants.
The expression of Gli1 and Ptch1 has been widely used as direct
readouts of the Hh pathway historically. However, a recent study
showed that although lower level of Hh signaling activates the
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Shh ligand in the ﬂoor plate cells inhibit their expression (Ribes et al.,
2010). Based on this observation, our gene expression analysis showing
the dorsal restriction of Gli1 and Ptch1 in Sufumutant spinal cords, but
not in Gli1;Sufu and Gli2;Sufu double mutant spinal cords, provides fur-
ther support for the conclusion that both Gli1 and Gli2 are required for
the maximal activation of Hh pathway in the Sufumutant spinal cords.
A role for Gli3 repressor activity in D/V patterning of the Sufu mutant
spinal cord
Although our data clearly indicated that direct activation of Gli2
and Gli3 activators is required for Hh pathway activation, it does
not rule out the possibility that a decrease in Gli repressor levels
also contributes to the Hh pathway activation in Sufu mutants. In
fact, a recent study in which endogenous Gli3 is replaced with an ob-
ligate repressor form (Gli3Δ699) partially restored D/V patterning of
the spinal cord in Sufu mutants, suggesting that Hh pathway activa-
tion in Sufu mutants is subject to the repressive effect of Gli3 (Wang
et al., 2010). The caveat of that study is that by replacing Gli3 with
an obligate repressor form, it produced more Gli3 repressor than
what is normally present in the cells. In our current study, we utilized
both gain- and loss-of-function approaches to investigate the roles of
Gli3 repressor in D/V patterning of the Sufu mutant spinal cords. We
found that removing Gli3 from Gli2+/−;Sufu−/− mutants exacerbates
the ventralization of the spinal cord, suggesting that the dorsal ex-
pansion of ventral cell types in the Sufumutant spinal cord is antago-
nized by remaining Gli3 repressor. On the other hand, replacing one
copy or both copies of Gli2 with Gli3 restores the spinal cord D/V pat-
terning more efﬁciently than simply removing Gli2 in Sufu mutants,
consistent with the conclusion that Hh pathway activation in Sufu
mutants is indeed inﬂuenced by the level of Gli3 repressor. In sum-
mary, we conclude that Hh pathway activation in Sufu mutants is
the combined result of activation of Gli2 and Gli3 activators and a
simultaneous down regulation of Gli repressors.
A positive role of Sufu in Hh signaling
In addition to its role in inhibiting the activator activity of Gli pro-
teins, Sufu protects Gli2 and Gli3 proteins from Spop-mediated pro-
teasomal degradation (Chen et al., 2009; Zhang et al., 2006, 2009).
It was proposed that by protecting Gli proteins from degradation,
Sufu might play an additional positive role in Hh signaling (Chen et
al., 2009). However, no genetic data suggested that this is the case
in vivo. In the current study, we provide two pieces of evidence argu-
ing that Sufu indeed plays a positive role in maximizing Hh pathway
activation. First, we show that ﬂoor plate and V3 interneurons are
present in Gli1mutants but not in Gli1;Sufu double mutants. Previous
reports indicated that the levels of both Gli2 and Gli3 are greatly de-
creased in the absence of Sufu (Chen et al., 2009; Jia et al., 2009). We
show that the level of Gli3 protein remains low in Gli1;Sufu double
mutants compared to wild type or Gli1 mutants (Supplemental Fig.
5). Although due to technical limitation, we have not been able to
measure the level of Gli2 protein in Gli1;Sufu mutants, we speculate
that its level should be lower than that in wild type and Gli1mutants.
Therefore, it is possible that the combined activator activities of Gli2
and Gli3 are not sufﬁcient to support the development of ﬂoor plate
and V3 interneurons in Gli1;Sufu double mutants. Second, we show
that ﬂoor plate and V3 interneurons, although reduced in number,
are present in Gli23ki homozygous mutants, but are absent in Gli23ki;
Sufu double mutants. Again, we argue that in the absence of Sufu,
the level of Gli3 activator in the embryos is not high enough for the
formation of these ventral-most cell types. In summary, our data
show that Sufu does play a positive role in Hh pathway activation
by stabilizing Gli2 and Gli3, which can only be revealed when the
overall Gli activator activities are reduced in the embryos.How does Sufu exert this positive function in Hh signaling? Data in
Drosophila and some studies in mammals indicated that Sufu remains
associated with Gli proteins in the presence of Hh ligands (Chen et al.,
2009; Sisson et al., 2006). It is conceivable that Hh pathway activation
in the presence of Sufu leads to less efﬁcient Gli degradation due to
the protective function of Sufu. However, some recent studies using
newly developed antibodies suggested that Hh ligands activate Gli
proteins by inducing the dissociation between endogenous Gli and
Sufu (Humke et al., 2010; Tukachinsky et al., 2010). This model ap-
pears to be at odds with our genetic data showing the positive func-
tion of Sufu because it proposes that Sufu no longer directly
interacts with Gli proteins once the Hh pathway is activated. One pos-
sible scenario is that in the presence of Sufu, a pool of inactive Gli pro-
teins are protected by Sufu and can be subsequently activated to
allow continuous maximal activation of Hh signaling. In contrast,
the Gli proteins are depleted quickly (or are not allowed to accumu-
late) without the protection of Sufu in Sufu mutants, preventing sus-
tained maximal activation of Hh pathway. This effect becomes
apparent when total Gli activator activities are further reduced, as
in our Gli1;Sufu and Gli23ki;Sufu double mutants.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.11.022.Acknowledgment
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